Shcherbakova E G, Rastunova G A, Vvedenskaia O I, Zhuravleva T P, Medvedeva M M
Antibiotiki. 1979 Sep;24(9):679-84.
The effect of gentamicin sulphate and its combination will prodigiozan on antibody formation in experiments and the levels of the immunobiologic reactivity of patients with purulent inflammatory processes was studied with a purpose of developing rational schemes of antibiotic therapy of infectious diseases. A decrease in the titers of the antibodies to Aeromonas and the number of antibody-forming cells in the spleen was noted on repeated administration of gentamicin to albino mice in a dose of 20 mg/kg. This was prevented by the use of prodigiozan in a dose of 500 micrograms/kg once every 4 days. The use of gentamicin in patients with purulent inflammatory diseases in doses of 40 or 80 mg twice a day for 7--10 days had no significant effect on the titers of IgA, IgG, IgM, lysozyme blood serum levels, serum bactericidal activity and absorption activity of the peripheral blood neutrophils. Still, it induced a marked suppression of the neutrophil digestive capacity as compared to the initial levels, especially on administration of gentamicin in a dose of 40 mg twice a day. An increase in the level of IgM and no suppression of the neutrophil digestive capacity were noted after completion of the therapy in the patients treated with gentamicin administered in a dose of 40 mg twice a day and prodigiozan administered in a dose of 50 micrograms once every 4 days. It is recommended to use prodigiozan in combinaed therapy with gentamicin for correction of the changes in the specific and nonspecific protective forces of the host.
研究了硫酸庆大霉素及其与灵菌红素联合应用对实验中抗体形成的影响,以及对化脓性炎症患者免疫生物学反应水平的影响,目的是制定传染病抗生素治疗的合理方案。给白化小鼠反复注射剂量为20mg/kg的庆大霉素后,发现其抗气单胞菌抗体滴度和脾脏中抗体形成细胞数量降低。每4天一次使用剂量为500微克/千克的灵菌红素可防止这种情况发生。化脓性炎症疾病患者每天两次使用剂量为40或80mg的庆大霉素,持续7 - 10天,对IgA、IgG、IgM滴度、血清溶菌酶水平、血清杀菌活性和外周血中性粒细胞的吸收活性没有显著影响。然而,与初始水平相比,它诱导了中性粒细胞消化能力的显著抑制,尤其是每天两次给予40mg庆大霉素时。在每天两次给予40mg庆大霉素和每4天一次给予50微克灵菌红素治疗的患者完成治疗后,观察到IgM水平升高且中性粒细胞消化能力未受抑制。建议将灵菌红素与庆大霉素联合用于纠正宿主特异性和非特异性保护力的变化。